|
 |
** CLICK HERE VIEW AND BUY OUR PRODUCTS **
Executive Summary
Sleep apnoea is a serious medical disorder, affecting 4% of men and 2% of women. It is characterized by repetitive reductions of airflow during sleep due to the collapse of the pharyngeal airway, causing loud snoring, brief awakenings, hypoxemia and elevated blood pressure. Millions of apnoea patients suffer from excessive daytime sleepiness, headaches and hypertension. There is growing evidence that chronic sleep apnoea runs in families, and is associated with increased morbidity and mortality. Sleep apnoea is relatively unknown, with only about 15% diagnosed so far.
Sleep apnoea can only be diagnosed by a sleep study, costing anywhere from £700 to £1400. Unattended ambulatory studies, which are considered least expensive, are often unreliable. There is therefore a need for a low cost screening device, which may help screen the general population and locate potential patients, and at the same time help minimize unnecessary and expensive studies.
The FDA and CE approved SleepStrip® is a disposable home screening test for sleep apnoea. Several research studies have shown that its indications correlate well with those of formal sleep studies. It is now available through health-care providers worldwide at a low price to the public as a self-administered test.
Relevant patents have been applied for and granted and clinical studies performed in renowned sleep labs have proven its accuracy and effectiveness. Similar screening devices for other medical disorders are already under development.
